MTOR and hepatocellular carcinoma: More recently, overexpression of BZW2 has been identified to be associated with hepatoma cell drug resistance, and inhibition of BZW2 inhibits cell proliferation, migration, and invasion by regulating PI3K/Akt/mTOR signaling pathway [11].